Ep-CAM expression in squamous cell carcinoma of the esophagus: a potential therapeutic target and prognostic marker
about
EpCAM (CD326) finding its role in cancerCirculating Tumor Cells: A Window Into Tumor Development and Therapeutic EffectivenessEpCAM in carcinogenesis: the good, the bad or the uglyExpression of natriuretic peptide receptor-A in esophageal squamous cell carcinomas and the relationship with tumor invasion and migrationRNA aptamer against a cancer stem cell marker epithelial cell adhesion molecule.High interstitial fluid pressure is associated with low tumour penetration of diagnostic monoclonal antibodies applied for molecular imaging purposes.Heterodimeric bispecific single-chain variable-fragment antibodies against EpCAM and CD16 induce effective antibody-dependent cellular cytotoxicity against human carcinoma cells.High EpCAM expression is linked to proliferation and lauren classification in gastric cancer.An open-label, randomized phase II study of adecatumumab, a fully human anti-EpCAM antibody, as monotherapy in patients with metastatic breast cancer.Using DNA aptamer probe for immunostaining of cancer frozen tissues.Epithelial cell adhesion molecule in human hepatocellular carcinoma cell lines: a target of chemoresistence.Using aptamers to elucidate esophageal cancer clinical samplesDetection of soluble EpCAM (sEpCAM) in malignant ascites predicts poor overall survival in patients treated with catumaxomab.High expression of TROP2 correlates with poor prognosis in pancreatic cancer.Validation of esophageal squamous cell carcinoma candidate genes from high-throughput transcriptomic studies.A phase I clinical study of VB4-845: weekly intratumoral administration of an anti-EpCAM recombinant fusion protein in patients with squamous cell carcinoma of the head and neck.Expression of EpCAM(MF) and EpCAM(MT) variants in human carcinomas.Cancer stem cells in human digestive tract malignancies.Epithelial cell adhesion molecule is expressed in a subset of sarcomas and correlates to the degree of cytological atypia in leiomyosarcomas.Context-dependent adaption of EpCAM expression in early systemic esophageal cancer.EPCAM-A novel molecular target for the treatment of pediatric and adult germ cell tumors.PSMA, EpCAM, VEGF and GRPR as imaging targets in locally recurrent prostate cancer after radiotherapy.Imaging prostate cancer lymph node metastases with a multimodality contrast agent.Ep-CAM is a significant prognostic factor in pancreatic cancer patients by suppressing cell activity.A genome-wide expression analysis identifies a network of EpCAM-induced cell cycle regulators.Expression of epithelial cell adhesion molecule (EpCAM) in oral squamous cell carcinoma.Side-by-side analysis of five clinically tested anti-EpCAM monoclonal antibodies.Expression of Ep-CAM, but not of E48, associates with nodal involvement in advanced squamous cell carcinomas of the larynx.Is minimal residual lymph node disease in papillary thyroid cancer of prognostic impact? An analysis of the epithelial cell adhesion molecule EpCAM in lymph nodes of 40 pN0 patients.Loss of membranous expression of the intracellular domain of EpCAM is a frequent event and predicts poor survival in patients with pancreatic cancer.High Expression of EpCAM and Sox2 is a Positive Prognosticator of Clinical Outcome for Head and Neck CarcinomaEpCAM ectodomain EpEX is a ligand of EGFR that counteracts EGF-mediated epithelial-mesenchymal transition through modulation of phospho-ERK1/2 in head and neck cancers
P2860
Q24653692-57A22843-659A-4283-97D4-1F51D0194678Q26827815-5F7616D8-9814-4FF6-9A94-CBBF8276B181Q28293163-50AFD0C7-F18F-4C21-AE62-2626E25D8A91Q33685072-422841F6-A7B0-47D8-B299-1ED0370E9BDBQ33807710-7C85F91C-A90F-4D1C-B942-5082183E96BDQ34270696-DEB58725-75C3-46C7-A86E-8308301FDF12Q34404833-0598517E-19DA-4E37-BF76-E451D360F714Q34800662-E9232935-B588-49FB-8136-F5E305A89589Q34994161-D21B75E8-B72D-42FE-BA7F-DB3F78F93B74Q35054102-8D6292A6-0857-4D98-9889-E45CF5298102Q35960157-DC9F1972-684A-4D90-B067-1C45C56578B0Q36387782-36644D00-0264-4C3E-BAA0-0F060B17A6A0Q36413103-9361C3F3-C19C-4A8D-9EB9-5E23D9C8C840Q36944033-D5875F81-9DA1-4A14-AEF1-6E54E4D4369EQ37096472-24490090-1664-4BD5-ABA9-2529C49A1BAEQ37385588-3CC50083-338E-467C-B781-F9A37CE38351Q37716015-E4722EA4-2C42-4E9D-B66C-95784521AC80Q38601789-38CD81E3-AF32-4F9F-8356-E818EB10AB8DQ38932716-A76741C9-23D0-4E21-8CF3-BCA5BFA602F4Q39076253-5F30ECF3-CEFA-4D69-85C3-73D419658625Q39276591-25D5E02F-692A-4E74-9F09-0CC34AD07D16Q39357182-DFD358C7-3909-435C-8E2D-8510722FB014Q39549282-1664BFEB-14C5-4004-8E6F-7790B8E70A2CQ39576941-AD1143D7-0FEE-4DAC-825D-16E21DC7844EQ39918688-42B40204-1544-4A06-AD0E-8D85264F1C7DQ41324942-7B7E5B86-E417-4F7E-9460-CCF1A6891213Q41670912-B8A1977B-8774-4C6E-A152-E66D166DA49FQ43844162-45123F00-6F07-478B-AD10-45D9412A3A65Q47850959-A865E519-8A25-4086-8DEC-054AA2FDB253Q54777332-72C890BE-DBBE-4BA3-B32E-A0B4443A565AQ57062512-F5790B7E-084D-4A75-9F1B-33D5EA14E9C4Q59127611-F56111B3-A743-43FD-BDB5-379F454A80AF
P2860
Ep-CAM expression in squamous cell carcinoma of the esophagus: a potential therapeutic target and prognostic marker
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Ep-CAM expression in squamous ...... c target and prognostic marker
@ast
Ep-CAM expression in squamous ...... c target and prognostic marker
@en
type
label
Ep-CAM expression in squamous ...... c target and prognostic marker
@ast
Ep-CAM expression in squamous ...... c target and prognostic marker
@en
prefLabel
Ep-CAM expression in squamous ...... c target and prognostic marker
@ast
Ep-CAM expression in squamous ...... c target and prognostic marker
@en
P2093
P2860
P356
P1433
P1476
Ep-CAM expression in squamous ...... c target and prognostic marker
@en
P2093
Alexander Rehders
Andreas Erbersdobler
Andreas M Luebke
Annika Siegmund
Claus F Eisenberger
Jan Schulte Am Esch
Matthias Peiper
Nikolas H Stoecklein
Pablo E Verde
Peter Scheunemann
P2860
P2888
P356
10.1186/1471-2407-6-165
P407
P577
2006-06-23T00:00:00Z
P5875
P6179
1018098729